GlassScriptPhysician profile
Raja Sawhney
NPI 1962612184
$18,537.22
in general payments reported to CMS, 2019-2025
17 companies · $2,714 in 2025
The $2,714 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,503 · 2020: $2,569 · 2021: $2,797 · 2022: $2,563 · 2023: $102 · 2024: $2,289 · 2025: $2,714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500 · Travel and Lodging: $962 · Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
| Travel and Lodging | $962.12 |
| Food and Beverage | $642.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $17,537.07 | 2019-2025 | |
| Medtronic USA, INC. | $268.71 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $120.39 | 2021-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $100.16 | 2023-2025 | Libtayo |
| Axogen | $64.39 | 2019 | |
| Organogenesis INC. | $60.53 | 2021-2022 | |
| Stryker Corporation | $55.79 | 2021 | |
| Abbvie INC. | $53.26 | 2022 | |
| Kerecis Limited | $51.01 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acclarent, INC | $47.61 | 2019 | |
| Amgen INC. | $40.70 | 2022-2023 | Otezla |
| Biofrontera INC. | $37.88 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Convatec INC. | $25.74 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.05 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.10 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $19.35 | 2023 | Adbry |
| Helsinn Therapeutics (U.S.), INC. | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raja Sawhney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.